Conventional drug development process

Lab Drug Synthesis
01Lab Drug Synthesis
Drug Characterization & Analysis
02Drug Characterization & Analysis
Simple in-vitro Cell Based Drug Evaluation
03Simple in-vitro Cell Based Drug Evaluation
Animal model Based Drug Evaluation
04Animal Model Based Drug Evaluation
Mass Production
05Mass Production

Innovative drug development process

Improved accuracy in evaluating new drug candidates
Reduced cost and duration of new drug development
Microfluidics-Standardized Drug Synthesis
01Microfluidics-Standardized Drug Synthesis

Standardization of drug synthesis through controlled flow patterns of microfluidic technology

Minimal batch-to-batch variability through a single continuous synthesis process

Multiple precursors Incorporatable through single-step synthesis

Drug Characterization & Analysis
02Drug Characterization & Analysis
Human Organ Model Chip Based Drug Evaluation
03Human Organ Model Chip Based Drug Evaluation

Accurate drug evaluation through human organ-level function simulation

Overcoming the cross-species difference from animal models

Accurate drug development for rare diseases through stem or patient cells

Minimum Animal Model Based Drug Evaluation
04Minimum Animal Model Based Drug Evaluation
Integrated Microfluidics Based Mass Production
05Integrated Microfluidics Based Mass Production

Integrated microfluidic reactor system

Mass production of standardized drug synthesis through reproduction of controlled flow patterns

Reproducing drug performance in clinical translation (bench to bedside)

Sitemap닫기

ABOUT
OVERVIEW
HISTORY
LEADERSHIP
ORGANIZATION
CI
CONTACT
TECHNOLOGY
HUMAN ORGAN MODEL CHIP
NANOMEDICINE
NANOMANUFACTURING
PIPELINE
MEPS-X
MG-X
SERVICE
SERVICE
NEWS
NOTICE
MEDIA
ARTICLE